4//SEC Filing
NASTECH PHARMACEUTICAL CO INC 4
Accession 0001209191-07-025228
$ATRXCIK 0000737207operating
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 5:27 PM ET
Size
9.0 KB
Accession
0001209191-07-025228
Insider Transaction Report
Form 4
BRANDT GORDON
Exec VP of Science and Clinica
Transactions
- Sale
Nastech Pharmaceutical Company Inc Common Stock
2007-04-20$13.22/sh−5,000$66,109→ 23,165 total - Exercise/Conversion
Nastech Pharmaceutical Company Inc Common Stock
2007-04-20$10.99/sh+5,000$54,950→ 28,165 total - Exercise of In-Money
Nastech Pharmaceutical Company Inc Stock Options
2007-04-20$10.99/sh−5,000$54,950→ 93,699 totalExercise: $10.99From: 2003-11-23Exp: 2007-11-25→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]On April 20, 2007, there was an exercise and sale of options pursuant to 10b5-1 Trading Plan adopted March 21, 2006.
Documents
Issuer
NASTECH PHARMACEUTICAL CO INC
CIK 0000737207
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000737207
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 5:27 PM ET
- Size
- 9.0 KB